Cardinal Health (CAH) | Financial Analysis & Statements
Cardinal Health Inc. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
65.6B
Gross Profit
2.4B
3.65%
Operating Income
763.0M
1.16%
Net Income
471.0M
0.72%
EPS (Diluted)
$1.97
Balance Sheet Metrics
Total Assets
58.1B
Total Liabilities
60.8B
Shareholders Equity
-2.7B
Cash Flow Metrics
Operating Cash Flow
619.0M
Free Cash Flow
555.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Cardinal Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 222.6B | 226.8B | 205.0B | 181.3B | 162.5B |
| Cost of Goods Sold | 214.4B | 219.4B | 198.1B | 174.8B | 155.7B |
| Gross Profit | 8.2B | 7.4B | 6.9B | 6.5B | 6.8B |
| Gross Margin % | 3.7% | 3.3% | 3.4% | 3.6% | 4.2% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 5.4B | 5.0B | 4.8B | 4.5B | 4.5B |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 5.4B | 5.0B | 4.8B | 4.5B | 4.5B |
| Operating Income | 2.3B | 2.1B | 1.8B | 1.6B | 1.8B |
| Operating Margin % | 1.0% | 0.9% | 0.9% | 0.9% | 1.1% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 215.0M | 51.0M | 84.0M | 147.0M | 180.0M |
| Other Non-Operating Income | -6.0M | -878.0M | -1.0B | -2.3B | -1.3B |
| Pre-tax Income | 2.1B | 1.2B | 663.0M | -784.0M | 323.0M |
| Income Tax | 532.0M | 348.0M | 332.0M | 153.0M | -289.0M |
| Effective Tax Rate % | 25.3% | 29.0% | 50.1% | 0.0% | -89.5% |
| Net Income | 1.6B | 853.0M | 331.0M | -937.0M | 612.0M |
| Net Margin % | 0.7% | 0.4% | 0.2% | -0.5% | 0.4% |
| Key Metrics | |||||
| EBITDA | 3.2B | 2.8B | 2.5B | 2.3B | 2.6B |
| EPS (Basic) | $6.48 | $3.48 | $1.27 | $-3.35 | $2.09 |
| EPS (Diluted) | $6.45 | $3.45 | $1.26 | $-3.35 | $2.08 |
| Basic Shares Outstanding | 241000000 | 245000000 | 261000000 | 279000000 | 292000000 |
| Diluted Shares Outstanding | 241000000 | 245000000 | 261000000 | 279000000 | 292000000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Cardinal Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 3.9B | 5.1B | 4.1B | 4.7B | 3.4B |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 13.2B | 12.1B | 11.1B | 10.6B | 9.1B |
| Inventory | 16.8B | 15.0B | 16.1B | 15.6B | 14.6B |
| Other Current Assets | 2.4B | 2.7B | 2.3B | 2.0B | 2.8B |
| Total Current Assets | 36.4B | 34.9B | 33.7B | 32.9B | 31.0B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 2.2B | 1.9B | 1.8B | 1.7B | 1.7B |
| Goodwill | 21.4B | 11.2B | 10.7B | 13.5B | 18.1B |
| Intangible Assets | 2.9B | 1.7B | 1.5B | 1.8B | 2.1B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 1.7B | 1.3B | 1.1B | 953.0M | 951.0M |
| Total Non-Current Assets | 16.7B | 10.2B | 9.6B | 10.9B | 13.4B |
| Total Assets | 53.1B | 45.1B | 43.3B | 43.9B | 44.5B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 34.7B | 31.8B | 29.9B | 27.1B | 23.7B |
| Short-term Debt | 550.0M | 434.0M | 792.0M | 580.0M | 871.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | 42.0M | - | 96.0M |
| Total Current Liabilities | 38.9B | 35.6B | 33.7B | 30.6B | 27.6B |
| Non-Current Liabilities | |||||
| Long-term Debt | 8.0B | 4.7B | 3.9B | 4.7B | 5.4B |
| Deferred Tax Liabilities | - | - | 8.7B | 9.3B | 9.7B |
| Other Non-Current Liabilities | 8.9B | 8.0B | 8.7B | 9.3B | 9.7B |
| Total Non-Current Liabilities | 16.9B | 12.7B | 12.6B | 14.0B | 15.0B |
| Total Liabilities | 55.8B | 48.3B | 46.3B | 44.6B | 42.7B |
| Equity | |||||
| Common Stock | 3.0B | 2.9B | 2.7B | 2.8B | 2.8B |
| Retained Earnings | 783.0M | -286.0M | -642.0M | -280.0M | 1.2B |
| Treasury Stock | 6.4B | 5.7B | 4.9B | 3.1B | 2.2B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | -2.6B | -3.2B | -3.0B | -706.0M | 1.8B |
| Key Metrics | |||||
| Total Debt | 8.5B | 5.1B | 4.7B | 5.3B | 6.2B |
| Working Capital | -2.5B | -756.0M | -3.0M | 2.4B | 3.4B |
Balance Sheet Composition
Cardinal Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 1.6B | 853.0M | 331.0M | -937.0M | 612.0M |
| Depreciation & Amortization | 790.0M | 710.0M | 692.0M | 692.0M | 783.0M |
| Stock-Based Compensation | 244.0M | 121.0M | 96.0M | 81.0M | 89.0M |
| Working Capital Changes | 83.0M | 1.9B | 1.5B | 946.0M | -163.0M |
| Operating Cash Flow | 2.9B | 3.5B | 2.5B | 796.0M | 1.8B |
| Investing Activities | |||||
| Capital Expenditures | -547.0M | -499.0M | -469.0M | -356.0M | -400.0M |
| Acquisitions | -5.2B | -1.2B | -10.0M | 901.0M | -3.0M |
| Investment Purchases | 0 | -554.0M | -7.0M | -78.0M | -22.0M |
| Investment Sales | 202.0M | 385.0M | 32.0M | 100.0M | 47.0M |
| Investing Cash Flow | -5.6B | -1.8B | -454.0M | 567.0M | -378.0M |
| Financing Activities | |||||
| Share Repurchases | -765.0M | -750.0M | -2.0B | -1.0B | -200.0M |
| Dividends Paid | -494.0M | -499.0M | -525.0M | -559.0M | -573.0M |
| Debt Issuance | 3.7B | 1.1B | 0 | 0 | - |
| Debt Repayment | -445.0M | -783.0M | -579.0M | -885.0M | -570.0M |
| Financing Cash Flow | 1.9B | -847.0M | -3.1B | -2.5B | -1.3B |
| Free Cash Flow | 1.8B | 3.3B | 2.4B | 2.8B | 2.0B |
| Net Change in Cash | -724.0M | 827.0M | -972.0M | -1.1B | 122.0M |
Cash Flow Trend
Cardinal Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
29.50
Forward P/E
17.67
Price to Book
-17.89
Price to Sales
0.20
PEG Ratio
1.47
Profitability Ratios
Profit Margin
0.68%
Operating Margin
1.23%
Return on Equity
-59.26%
Return on Assets
3.50%
Financial Health
Current Ratio
0.91
Debt to Equity
-3.34
Beta
0.65
Per Share Data
EPS (TTM)
$6.94
Book Value per Share
$-12.22
Revenue per Share
$1,025.88
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| CAH | 48.2B | 29.50 | -17.89 | -59.26% | 0.68% | -3.34 |
| McKesson | 103.2B | 24.33 | -1,040.14 | -194.51% | 1.09% | -88.23 |
| Cencora | 60.6B | 37.46 | 31.84 | 133.47% | 0.50% | 472.58 |
| Henry Schein | 9.0B | 23.94 | 2.79 | 8.70% | 3.02% | 71.74 |
| Patterson Companies | 2.8B | 20.48 | 2.80 | 14.11% | 2.13% | 88.87 |
| Owens & Minor | 184.1M | - | - | -196.39% | -12.45% | -4.86 |
Financial data is updated regularly. All figures are in the company's reporting currency.





